Importantly, 4E-BP3 may be upregulated in several cancer types (for example, RCC or PNET) for which the mTORC1 inhibitors (the rapalogs, temsirolimus and everolimus) have been approved for treatment12, 13, 14. The gene discussed is EIF4EBP3; the disease is cancer.